Researchers Use Nanoparticles to Test Treatment for Liver Disease

June 25, 2018 | Katie Neith

In an effort to improve options for those with liver cancer, a group of researchers have identified a way of potentially treating a broad range of liver diseases and perhaps even other types of cancer.

Continue Reading

New Genome-editing Platform Poised to Fuel the Next Generation of Genetic Medicines

July 16, 2018 | Zen Vuong

A novel gene-editing tool discovered at City of Hope has the potential to treat a variety of genetic diseases.

City of Hope Awarded $3.7 million to Develop Glioblastoma Clinical Trial

June 29, 2018 | Letisia Marquez

California Institute for Regenerative Medicine has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients, which would genetically alter blood stem cells to better tolerate chemotherapy.

Researcher's Ovarian Cancer Discovery Takes on Special Meaning

June 27, 2018 | City of Hope

The results of a study published earlier this year by TGen researchers (City of Hope affiliate) in the journal Clinical Cancer Research suggest an existing leukemia drug, ponatinib, shows promise against SCCOHT.

New handheld heart monitor is a breakthrough for childhood cancer survivors

June 22, 2018 | Maxine Nunes

A new electronic monitor called Vivio, developed by Caltech with City of Hope, promises to make cardiac screening easier and more accessible for cancer patients and physicians.

City of Hope Guides ASCO’s New Geriatric Cancer Recommendations

June 8, 2018 | Saundra Young

City of Hope physicians Arti Hurria, M.D., a geriatric oncologist, and William Dale, M.D., Ph.D., a geriatrician and palliative care physician, co-chaired the panel that developed the new ASCO guidelines designed to help doctors assess and manage care for older adults.

City of Hope Researchers Publish First Report on a Protein Inhibitor for Advanced Bladder Cancer

June 8, 2018 | Letisia Marquez

Advanced bladder cancer is particularly difficult to treat. The five-year survival rate for Stage 4 bladder cancer is only about 15 percent. Now, City of Hope researchers have discovered a that a novel drug blocks a key protein that drives the disease.

Researchers Discover Breakthrough Treatment For Advanced Squamous Cell Carcinoma

June 7, 2018 | Maxine Nunes

A couple of years ago, Timothy Satterfield, a retired chef, noticed a tiny mole on his forehead. He was referred to City of Hope, where a breakthrough immunotherapy trial is proving to be a game changer.